Safety and pharmacokinetics of subcutaneous ceftriaxone administered with or without recombinant human hyaluronidase (rHuPH20) versus intravenous ceftriaxone administration in adult volunteers

10.1016/0002-9610(79)90121-1

Hadaway L., 2007, Preventing a complication of IV catheterization. Am J Nurs, 107, 64

Liau DW. Injuries and liability related to peripheral catheters: a closed claims analysis. Available at: http://www.asahq.org/Newsletters/2006/06-06/liau06_06.html [Last accessed 25 September 2009]

Sasson M, 2001, Am Fam Physician, 64, 1575

10.1111/j.1532-5415.1999.tb01907.x

Farrand S, 1996, Br J Hosp Med, 55, 690

10.1002/mus.20909

10.1177/104990910001700513

10.1016/j.jconrel.2006.05.027

Britton RC, 1953, Surgery, 33, 917

10.1517/17425247.4.4.427

Hylenex (product information). Deerfield, IL: Baxter Healthcare Corporation, 2009

10.1097/01.NAN.0000292572.70387.17

10.1089/jpm.2007.0126

Thomas JR, Yocum RC, Haller MF, et al. The INFUSE-Morphine IIB Study: use of recombinant human hyaluronidase (rHuPH20) to enhance the absorption of subcutaneous morphine in healthy volunteers. J Pain Symptom Manage 2009;38:673-682

Thomas JR, Wallace MS, Yocum RC, et al. The INFUSE-Morphine Study: the use of recombinant human hyaluronidase (rHuPH20) to enhance the absorption of subcutaneously administered morphine in patients with advanced illness. J Pain Symptom Manage 2009;38:663-672

10.1089/jpm.2007.0037

10.1542/peds.2008-3588

Ceftriaxone (package insert). Weston, FL: Apotex Corporation, 2008

10.1128/AAC.24.5.812

Rocephine (package insert). Neuilly-sur-Seine, France: Roche Laboratories Inc., 2005

10.1159/000238342

Melin-Coviaux F, 2000, Revue de Geriatrie, 25, 337

10.1128/AAC.21.6.957

10.1128/AAC.40.2.485

Rocephin (package insert). Nutley, NJ: Roche Laboratories Inc., 2009

10.1046/j.1365-2125.1996.03967.x

Bricaire F, 1988, Pathol Biol (Paris), 36, 702